Skip to content

Determination of Protein Requirements in Pregnancy

Determination of Protein Requirements in Healthy Pregnant Women Using Indicator Amino Acid Oxidation Technique

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01784198
Enrollment
20
Registered
2013-02-05
Start date
2011-04-30
Completion date
2014-03-31
Last updated
2017-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy

Keywords

pregnancy, protein requirements, Indicator Amino acid oxidation, Stable isotopes

Brief summary

Protein is an essential part of our diet. It is used to build muscle and body tissue, send signals throughout our body and to support the immune system. Dietary protein is even more crucial during pregnancy as it is needed for healthy growth and development of the baby. There is very minimal data available on how much additional protein is required during pregnancy. Current recommendations are based on older techniques such as nitrogen balance studies of non-pregnant adults and minimally based on pregnancy specific data. There is no scientific information regarding the amount of protein needed during different stages of pregnancy. The investigators hypothesize that the current recommendations of protein intake during pregnancy are underestimated. The goal of this study is to measure protein requirement in healthy pregnant women (19-35y)using a more quick and modern technique called the indicator amino acid oxidation technique (IAAO).

Interventions

DIETARY_SUPPLEMENTProtein Intake

Oral consumption of Eight hourly experimental meals- Includes 4 tracer-free experimental meals containing a mixture of free amino acids, calories from a flavored liquid and protein free cookies and 4- labeled amino acid experimental meals.

Sponsors

Canadian Institutes of Health Research (CIHR)
CollaboratorOTHER_GOV
University of British Columbia
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
19 Years to 35 Years
Healthy volunteers
No

Inclusion criteria

Healthy pregnant women * Singleton pregnancy * Maternal age 19-35y * In good health (free of chronic/acute disease,full range of physical mobility) * Healthy pre-pregnancy body mass index

Exclusion criteria

Women * not pregnant * Pregnant with more than one child * Singleton pregnancy outside the age range of 19-35y * Not in good health or have a metabolic, neurological, genetic, or immune disorder, including gestational diabetes or anemia * smoke or consume alcohol during their pregnancy * classified as underweight (\<18.5 kg/m2), overweight (25-30 kg/m2) or obese (\>30 kg/m2) * allergic to eggs and egg protein * severe nausea/vomiting throughout their pregnancy

Design outcomes

Primary

MeasureTime frameDescription
13 Carbon dioxide production8 hours (1 study day)Urine and breath samples will be collected during the study to measure the rate of oxidation of tracer in expired breath and flux by enrichment in urine.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 19, 2026